United States· US:62225-600_4ef3b158-3042-6a1f-e063-6394a90a807f
Omidria
A phenylephrine and ketorolac product containing phenylephrine; ketorolac, registered in United States by Omeros Corporation. The same ATC class is registered in 6 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Phenylephrine and ketorolac is registered in 6 of 19 countries.
Countries holding a registration under ATC S01FB51 (phenylephrine and ketorolac), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 4 of them publish a price we can compare per daily dose
Phenylephrine and ketorolac · ATC S01FB51
6 / 19 countries
- Belgiumprice
- Denmark
- Finlandprice
- Polandprice
- United Kingdom
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- PHENYLEPHRINE; KETOROLAC
- Manufacturer
- Omeros Corporation
- Country
- United States (US)
- ATC code
- S01FB51
- ATC class
- Phenylephrine and ketorolac
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Phenylephrine and ketorolac in 3 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/4f023007-2e6d-4ff5-98c9-8b1477dc6d3f GET /v1/drugs/4f023007-2e6d-4ff5-98c9-8b1477dc6d3f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "INTRAOCULAR",
"source": "ndc",
"strength": "10.16; 2.88",
"substance": "PHENYLEPHRINE; KETOROLAC",
"productndc": "62225-600",
"dosage_form": "INJECTION, SOLUTION, CONCENTRATE",
"dea_schedule": null,
"strength_unit": "mg/mL; mg/mL",
"application_number": "NDA205388",
"marketing_category": "NDA"
}See everything about phenylephrine and ketorolac.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.